허승범

All filings by 허승범 on record concern 삼일제약, in the capacity of chief executive. Between 9 April 2021 and 12 October 2026, the trades on record add up to 52 filings.

Both buying and selling appear: 34 purchases worth €31k, against 16 sales. The totals exclude 49 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 3 purchases and 2 sales.

Across 31 purchases, this insider has always bought alone, with no colleague buying within 30 days.

Most recently, on 12 October 2026, the filings show a transaction in 삼일제약. The most recent open-market purchase was published on 22 May 2026, 149 days ago. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.